JR

Julie Ross

Active Director Additional Director DIN 11205888
DIN 11205888 First appointment Jul 2025 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Julie Ross

Data last updated:

Julie Ross is an Additional Director at Advanced Clinical India Private Limited (since 2025). The company operates in Professional Services.

DIN 11205888
Primary Designation Additional Director
Industry Professional Services
First Appointment 25 Jul 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director25 Jul 20252024Active

Board colleagues of Julie Ross

Directorship timeline

Open interactive timeline →
Advanced Clinical India Private Limited
Premium access

Shareholding and investment profile for Julie Ross

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Julie Ross

Julie Ross currently holds 1 directorship: Advanced Clinical India Private Limited (Additional Director, since 25 Jul 2025).

Julie Ross was first appointed on 25 Jul 2025 as Additional Director at Advanced Clinical India Private Limited.

The current boards of Julie Ross's companies include Andreas Christian Amrein (Advanced Clinical India Private Limited), Bharat Balkrishna Doshi (Advanced Clinical India Private Limited), Sangeeta Sajjan Jhunjhunwala (Advanced Clinical India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available